Showing results (2221-2230 of 2,371) with videos related to

Sort By:
Pageof 238
Future Medicinal Chemistry|February 17, 2015
Progress toward JAK1-selective inhibitorsChristel J Menet, Oscar Mammoliti, Miriam López-Ramos
Future Medicinal Chemistry|July 26, 2022
The story of EGFR: from signaling pathways to a potent anticancer targetSaloni Ramani, Sayalee Samant, Sonal M Manohar
Future Medicinal Chemistry|July 21, 2022
Novel approaches for the treatment of infections due to multidrug-resistant bacterial pathogensMohmmad Imran, Mohammad Naiyaz Ahmad, Arunava Dasgupta, et al.
Future Medicinal Chemistry|September 28, 2021
Development and investigation of thiazolidinedione and pyrazoline compounds as antiangiogenic weapons targeting VEGFR-2Neha Upadhyay, Kalpana Tilekar, Sabreena Safuan, et al.
Future Medicinal Chemistry|September 23, 2021
Xanthohumol alleviates T2DM-induced liver steatosis and fibrosis by mediating the NRF2/RAGE/NF-κB signaling pathwayWei Wang, Zhixi Chen, Tiansheng Zheng, et al.
Future Medicinal Chemistry|June 30, 2018
Identification of some benzoxazepines as anticancer agents inducing cancer cell apoptosisMohamed S Rashad, Hanan H Georgey, Riham F George, et al.
Future Medicinal Chemistry|July 3, 2018
Evolution strategy of ROS1 kinase inhibitors for use in cancer therapySiming Liu, Haikui Yang, Ying Jiang, et al.
Future Medicinal Chemistry|April 21, 2018
Synthesis & α-glucosidase inhibitory & glucose consumption-promoting activities of flavonoid-coumarin hybridsHua Sun, Xiaotong Song, Yunchang Tao, et al.
Future Medicinal Chemistry|April 21, 2018
Lysine acetyltransferase inhibitors: structure-activity relationships and potential therapeutic implicationsFrancesco Fiorentino, Antonello Mai, Dante Rotili
Future Medicinal Chemistry|May 31, 2018
Recent advances in CDK inhibitors for cancer therapyAmy B Heptinstall, Iws Adiyasa, Céline Cano, et al.
Pageof 238